THYROID EYE DISEASE (TED)
Clinical trials for THYROID EYE DISEASE (TED) explained in plain language.
Never miss a new study
Get alerted when new THYROID EYE DISEASE (TED) trials appear
Sign up with your email to follow new studies for THYROID EYE DISEASE (TED), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for bulging eyes in thyroid disease
Disease control CompletedThis study looked at how well and how safely the drug IBI311 works for people with thyroid eye disease (TED). It included 91 adults who had already completed a previous study on IBI311. The main goal was to see if the drug could reduce eye bulging by at least 2 millimeters withou…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Eyelid injection offers relief for thyroid eye disease patients
Symptom relief CompletedThis study tested a steroid injection into the eyelid to treat upper eyelid retraction caused by thyroid eye disease. Fifteen adults with inactive disease received the injection, and doctors measured changes in eyelid position and eye pressure one month later. The goal was to see…
Matched conditions: THYROID EYE DISEASE (TED)
Phase: NA • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Symptom relief
Last updated May 13, 2026 15:59 UTC
-
Hidden struggles: study reveals mental health burden of thyroid eye disease
Knowledge-focused CompletedThis completed study from Thomas Jefferson University involved 20 adults with thyroid eye disease and their caregivers. Researchers conducted focus groups and interviews to understand how the condition affects mood, relationships, work, and daily life. Participants also completed…
Matched conditions: THYROID EYE DISEASE (TED)
Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC